Tag: cell-based therapy

Cell therapy may provide benefit for “no option” critical limb ischaemia...

Two-year results from the MOBILE (Marrowstim treatment of limb ischaemia in patients with severe peripheral arterial disease) trial indicate that injecting concentrated bone marrow...

New update on Phase III clinical trials of REX-001 cell-based therapy...

Rexgenero, a regenerative medicine company working to develop cell-based therapies to treat critical limb ischaemia (CLI), has presented an update on its two Phase...